All Posts
0 posts
Prevention and Control of Cardiovascular Diseases
Cardiovascular disease prevention operates on a continuum from population-level interventions to individual patient management. Pharmacists play crucial roles across all prevention levels, aligning with Sustainable Development Goal 3.4 to reduce premature NCD mortality by one-third by 2030.
Clinical Pharmacy
Current and Future Roles in Patient-Centered Cardiovascular Care
The management of cardiovascular diseases requires a paradigm shift from disease-focused to patient-centered care. This approach recognizes patients as active participants in their healthcare journey, with unique values, preferences, and needs.
Clinical Pharmacy
Screening and Identification of Clinical Manifestations of CVDs
Accurate blood pressure measurement is fundamental to hypertension diagnosis and management. Pharmacists must master both office and out-of-office measurement techniques.
Clinical Pharmacy
Supporting People with Cardiovascular Diseases Through Team-Based Care
Cardiovascular disease management requires moving beyond the traditional "silo mentality" to integrated, team-based care. The complexity of CVD, with its multiple risk factors, comorbidities, and long-term management needs, demands coordinated efforts across healthcare professions.
Clinical Pharmacy
Pharmaceutical Care: Basic Concepts & Communication Skills
The pharmacist should also be skilled to plan, direct and implement pharmaceutical care activities within various practice environments, such as community pharmacy, ambulatory care settings, managed or contractual care, home health services, long-term care facilities, inpatient hospital practice, and others. Allocating resources in the pharmacy is also a direct responsibility of the pharmacist.
Clinical Pharmacy
Pharmacological Treatment Strategies for Cardiovascular Conditions
Hypertension management follows evidence-based guidelines with specific recommendations for drug selection, combination therapy, and monitoring.
Clinical Pharmacy
Strategies for Medication Management, Adherence, and Digital Health Integration
Effective pharmacy practice requires strategic allocation of services based on patient risk and needs. A three-tiered approach optimizes resource utilization while ensuring high-risk patients receive comprehensive care.
Clinical Pharmacy
Clinical and Economic Outcomes Metrics for Cardiovascular Disease Services
Modern healthcare evaluation requires a holistic approach that considers clinical effectiveness, economic efficiency, and patient-centered outcomes. The ECHO model provides a framework for comprehensive assessment of pharmacy services.
Clinical Pharmacy
Chronic Kidney Disease - Clinical Pharmacy Study Note
CKD management requires a multidisciplinary approach. Pharmacists play crucial roles in medication optimization, monitoring for nephrotoxicity, managing complications (anemia, mineral disorders), patient education, and vaccination coordination.
Clinical Pharmacy
Individualization of Dosage Regimen
The dosage regimen is the schedule of medication administration, including time between doses, duration of treatment, and amount per dose. It also includes the formulation, route, dosing interval, and treatment length.
Clinical Pharmacy
Interpretation of Laboratory Results - Clinical Pharmacy Notes
Clinical laboratory test results are crucial parameters in diagnosis, monitoring, and screening. Approximately 70-80% of diagnostic decisions are based on laboratory results. With an increasing volume of tests ordered, clinicians must be proficient in test interpretation for optimal patient care and safety.
Clinical Pharmacy
Introduction to Clinical Pharmacy: A Complete Guide for Graduate Students
Clinical Pharmacy is the branch of pharmacy where pharmacists provide patient care that optimizes medication use and promotes health, wellness, and disease prevention. It is a patient-oriented practice that began in hospitals and clinics.
Clinical Pharmacy
Cardiovascular Disease: Types, Etiology, Diagnosis, Treatment & Prevention
Cardiovascular disease is a group of diseases affecting your heart and blood vessels. These diseases can affect one or many parts of your heart and/or blood vessels. A person may be symptomatic (physically experiencing the disease) or asymptomatic (not feeling anything at all).
Clinical Pharmacy
Pathophysiology and Therapeutics of Cardiovascular Diseases (CVDs)
Heart attacks and strokes are usually acute events and are mainly caused by a blockage that prevents blood from flowing to the heart or brain. The most common reason for this is a build-up of fatty deposits on the inner walls of the blood vessels that supply the heart or brain. Strokes can be caused by bleeding from a blood vessel in the brain or from blood clots.
Clinical Pharmacy
Pathophysiology and Therapeutics: Infectious Diseases
Infectious diseases are diseases in which tissue damage or dysfunction is produced by microorganisms.
Despite the availability and use of effective vaccines and antibiotics, and improvement in sanitation, infectious diseases remain an important health problem worldwide.
Clinical Pharmacy
Overview of Infectious Diseases
Pathogenesis: Reflects the relationship among the human host, the infectious agent, and the external environment. Infection occurs when an exogenous agent enters a host or when an endogenous agent overcomes innate immunity.
Clinical Pharmacy
Pathophysiology and Classification of Kidney Diseases
CKD affects 10-15% of adults in Western countries, with ~26 million in the USA classified as having CKD and another 20 million at increased risk. CKD is a major independent risk factor for cardiovascular morbidity and mortality.
Clinical Pharmacy
Pathophysiology of Nervous System
Neural circuits typically begin with a receptor that transduces a stimulus into membrane excitation, which then propagates through interconnected neurons.
Clinical Pharmacy
Nervous System Disorders
Nociception refers to the neural processing of noxious stimuli. Specialized nerve endings (nociceptors) respond to chemical, mechanical, and thermal stimuli. Pain pathways primarily travel via spinothalamic tracts to the thalamus and cerebral cortex.
Clinical Pharmacy
Clinical Pharmacology of Adverse Drug Reactions
Type A (Augmented): Pharmacological effect, dose-dependent, occurs frequently, often detected in clinical trials.
Type B (Bizarre): Idiosyncratic, rare, not dose-dependent, serious, not detected in clinical trials.
Clinical Pharmacy
Adverse Drug Reactions and Interactions - Part 2
An Adverse Drug Reaction (ADR) is defined as "a response to a medicinal product that is noxious and unintended". ADRs range from minor symptoms to life-altering events, often leading to hospital admission, prolonged stay, morbidity, and increased costs. Diagnosis is challenging as ADRs can mimic underlying diseases or go unrecognized.
Clinical Pharmacy
Neuropathology: A Pharmacological Perspective
Neuropathology involves the systematic recognition of patterns that deviate from normal CNS architecture. For pharmacy students, understanding these patterns is crucial for anticipating drug targets, predicting therapeutic responses, and recognizing adverse drug effects on the nervous system.
Clinical Pharmacy
Adverse Drug Reactions and Interactions -Study Notes
Harmful or seriously unpleasant effects occurring at doses intended for therapeutic (prophylactic or diagnostic) effect which call for reduction of dose or withdrawal of the drug or indicate caution in future use of the same drug.
Clinical Pharmacy
Introduction of Clinical Pharmacy - Study Notes
Clinical pharmacy comprises functions that promote the safe, effective, and economic use of medicines for individual patients. It shifts the focus from product-oriented roles to direct patient engagement.
Clinical Pharmacy